SkyRun Pharma Co., Ltd. – Trademark Portfolio
Entity Type: 16
SkyRun Pharma Co., Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include FARMASINO. The owner is based in Nanjing City, Jiangsu.
No. 9, Weidi Road
Nanjing City, Jiangsu 210033 , CN
Showing of trademarks Trademarks
Trademark Classifications
SkyRun Pharma Co., Ltd.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SkyRun Pharma Co., Ltd. have?
SkyRun Pharma Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 cancelled.
What trademark classes does SkyRun Pharma Co., Ltd. file in?
SkyRun Pharma Co., Ltd. files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are SkyRun Pharma Co., Ltd.'s most well-known trademarks?
SkyRun Pharma Co., Ltd.'s registered trademark portfolio includes well-known marks such as FARMASINO. These are among 1 currently registered trademark in the portfolio.
What is SkyRun Pharma Co., Ltd.'s trademark registration success rate?
SkyRun Pharma Co., Ltd. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.